Phoenix Rising supports the Millions Missing global day of protest
Phoenix Rising is delighted to support the demands being made in the ME/CFS community’s first-ever global day of protest …
Discuss the article on the Forums.

Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome.

Discussion in 'Latest ME/CFS Research' started by Dolphin, Jan 23, 2011.

Thread Status:
Not open for further replies.
  1. Dolphin

    Dolphin Senior Member

    Messages:
    10,680
    Likes:
    28,203
    Free full text at: http://www.behavioralandbrainfunctions.com/content/6/1/76

     
  2. Dolphin

    Dolphin Senior Member

    Messages:
    10,680
    Likes:
    28,203
    It is interesting that they try to die this in with viruses (amongst other things):

    I think if others had written it we wouldn't have heard about viruses.
     
  3. Dolphin

    Dolphin Senior Member

    Messages:
    10,680
    Likes:
    28,203
    Presuming they looked at all eight SF-36 subscales (they appear to), the fact that SF-36 General Health, Emotional Well-being (presumably role emotional) and Social Functioning (along with the other scales from other instruments) doesn't feel me with confidence that this is a marker of severity, but maybe I'm missing something.

    If they were wanting to look at symptom severity, it is also disappointing they didn't measure "symptoms" more directly (rather than moods, etc).

    They have the data so it is a pity they don't give us a breakdown by gender to see if it could be an issue.
     
  4. Dolphin

    Dolphin Senior Member

    Messages:
    10,680
    Likes:
    28,203
Thread Status:
Not open for further replies.

See more popular forum discussions.

Share This Page